Compare Oklo Inc (OKLO) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs Oscar Health Inc — how do they compare? Oklo Inc trades at $42.35 (market cap $7.92B), while Oscar Health Inc trades at $31.72 (market cap $9.80B). The key difference: Oscar Health Inc is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| OKLO | OSCR | |
|---|---|---|
Market Cap | $7.92B | $9.80B |
Sector | Technology | Health |
52-Week High | $174.14 | $33.01 |
52-Week Low | $36.84 | $10.85 |
Enterprise Value | $5.46B | $6.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $43.31, up 4.94% in the last 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The stock shows significant losses with a net income margin of -12,625.54% and negative cash flow from operations, but strong financing inflows support growth investments. Recent news highlights progress in small modular reactor projects amid sector volatility, with a 52-week low of $36.61 indicating potential support levels.
Outlook: Wall Street consensus is bullish with a $71.58 price target, driven by AI power demand and nuclear energy tailwinds. Risks include project delays, high cash burn, and lack of profitability. The stock offers high growth potential but requires tolerance for execution risk and extended timelines to commercialization.
OSCR trades at $33.01, up 2.36% today and near its 52-week high of $33.10, with a bullish technical trend supported by moving averages. The stock shows strong momentum, with Q1 and Q2 2026 earnings beating estimates, and revenue growth from $11.70B in 2025 to $15.30B in 2026. Analyst sentiment is mixed, with a consensus price target of $30.67 below the current price, but recent news highlights membership growth and cost control improvements.
The outlook for OSCR is cautiously optimistic, driven by robust revenue expansion and profitability improvements, though risks include high valuation multiples and reliance on sustained membership growth. Investors may find opportunity in the company's operational turnaround, but should monitor medical cost trends and competitive pressures in the health insurance sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
